TNDM · All filings · Read this filing
What changed 10-Q
Item 1. Legal Proceedings
2025-04-30 compared with 2024-11-06 · 1 added, 1 removed, 2 unchanged (50% of the section changed)
Legal Proceedings.
−Removed: Except as set forth above under the caption “Commitments and Contingencies - Legal and Regulatory Matters” in Part I, Notes to Unaudited Condensed Consolidated Financial Statements, Note 13 of this Quarterly Report, as of September 30, 2024, we do not believe there are any material pending legal proceedings to which we or any of our subsidiaries are a party or of which any of our property is subject.
+Added: Except as set forth above under the caption “Commitments and Contingencies - Legal and Regulatory Matters” in Part I, Notes to Unaudited Condensed Consolidated Financial Statements, Note 13 of this Quarterly Report, as of March 31, 2025, we do not believe there are any material pending legal proceedings to which we or any of our subsidiaries are a party or of which any of our property is subject.
See also “Patent litigation in the medical device industry is common, and we may be subject to litigation that could cause us to incur substantial costs and divert the attention of management from our business” in Part II, Item 1A of this Quarterly Report.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.